Acessibilidade / Reportar erro
Atualização Continuada • Arq. Bras. Oftalmol. 62 (1) • Fev 1999 • https://doi.org/10.5935/0004-2749.19990062   copiar

Olho seco

Dry eye

Autoria SCIMAGO INSTITUTIONS RANKINGS

Texto completo disponível apenas em PDF.

Agradecimento especial ao Dr. Kazuo Tsubota pela colaboração na revisão deste tema.

REFERÊNCIAS BIBLIOGRÁFICAS

  • 1
    Lemp MA. Dry eye syndromes: treatment and clinical trials. Adv Exp Med Biol 1994;350:553-9.
  • 2
    Nelson JD. Diagnosis of keratoconjunctivitis sicca. Int Ophthalmol Clin 1994;34(1):37-56.
  • 3
    Abelson M & Knight E. Dry eye therapy evaluation of current directions and clinical trials. Adv Exp Med Biol 1994;350:431-6.
  • 4
    Wolff E. The mucocutaneous junction of the lid and the distribution of the tear fluid. Trans Ophthalmol Soc UK 1946;66:291-308.
  • 5
    Tiffany JM. Composition and biophysical properties of the tear film knowledge and uncertainty. Adv Exp Med Biol 1994;350:231-8.
  • 6
    Dilly P N. Structure and function of the tear film. Adv Exp Med Biol 1994;350:239-47.
  • 7
    Prydal JI & Campbell FW. Study of precorneal tear film thickness and structure by interferometry and confocal microscopy. Invest Ophthalmol Vis Sci 1992;33:1996-2005.
  • 8
    Prydal JI, Artal P, Woon H & Campbell FW. Study of human precorneal tear film thickness and structure using laser interferometry. Invest Ophthalmol Vis Sci 1992;33:2006-11.
  • 9
    Chen HB, Yamabayashi S, Ou B, Tanaka Y, Ohni S & Tsukahara S. Structure and composition of rat precorneal tear film. Invest Ophthalmol Vis Sci 1997;38:381-7.
  • 10
    Tabbara KF & Wagoner MD. Diagnosis and management of dry eye syndrome. Int Ophthalmol Clin 1996;61-75.
  • 11
    Tsubota K, Fujishima H, Toda I, Katagiri S, Kawashima Y & Saito I. Increased leveis of Epstein Baar virus DNA in lacrimal glands of Sjögren's syndrome patients. Acta Ophthalmol Scandinavia 1995;73:425-30.
  • 12
    Warren DW. Hormonal influences on the lacrimal gland. Int Ophthalmol Clin 1994;34(1):19-26.
  • 13
    Rocha FJ, Sato EH, Sullivan BD & Sullivan DA. Comparative efficacy of androgen analogues in suppressing lacrimal gland inflammation in a mouse model (MRL/l yr) of Sjögren's syndrome. Adv Exp Med Biol 1994;350:697-700.
  • 14
    Sato EH, Ariga HH & Sullivan DA. Impact of androgen therapy in Sjögren's syndrome: hormonal influence on lymphocyte populations and Ia expression in lacrimal glands of MRL/MP-Ipr mice. Invest Ophthalmol Vis Sci 1992;33(8):2537-45.
  • 15
    Vendramini AC, Soo CH & Sullivan DA. Invest Ophthalmol Vis Sci 1991;32:3002.
  • 16
    Jones LT. The lacrimal secretory system and its treatment. Am J Ophthalmol 1966;62:47-60.
  • 17
    Clinch TE. Benedetto DA, Felbey NT & Laibson PR. Schirmer's test: a closer look. Arch Ophthalmol 1983;101:1383-6.
  • 18
    Lamberts DW, Foster CS & Perry HD. Schirmer test after topical anesthetic and the tear meniscus in normal eyes. Arch Ophthalmol 1979;97:1082-5.
  • 19
    Van Birjsterveld OP. Diagnostic teses in the sicca syndrome. Arch Ophthalmol 1969;82:10-4.
  • 20
    Tsubota K. The importance of the Schirmer test with nasal stimulation. Am J Ophthalmol 1991;111(1):106-8.
  • 21
    Adamson TC, Fox RI, Frisman DM & Howell FV. Immunohystologic analysis of lymphoid infiltrates in primary Sjögren's syndrome using monoclonal antibodies. J Immunol 1983;130:204.
  • 22
    Berfort R & Mendes NF. T and B lymphocytes in the human conjunctiva and lacrimal gland. ln: Silverstein A, O'Connor RG, eds. Immunology and Immunopathology of the Eye. New York: Masson Publishing, 1979;287.
  • 23
    Fox RI, Robinson CA, Curd JG, Kozin F & Howell FV. Sjögren's syndrome. Proposed criteria for classification. Arthritis and Rheum 1986;29(5):577-85.
  • 24
    Xu KP, Yagi Y & Tsubota K. Decreased in corneal sensivity and change in tear function in dry eye. Cornea 1996;15(3):235-9.
  • 25
    Lemp MA & Harnill JR. Factors affecting tear break up in normal eyes. Arch Ophthalmol 1973;89:103-5.
  • 26
    Mengher LS, Bron AJ, Tonge SR & Gilbert DJ. A non invasive instrument for clinicai assessment of the pre corneal tear film stability. Curr Eye Res 1985;4:9-!2.
  • 27
    Feenstra RPC & Tseng SCG. What is actually stained by rose bengal? Arch Ophthalmol 1992; 110:984-93.
  • 28
    Manning FJ, Webely SR & Foulks GN. Patient tolerance and ocular surface staining characteristics of lissamine green versus rose bengal. Ophthalmology 1995; 102(12):1953-7.
  • 29
    Tseng SCG. Evaluation of the ocular surface in dry eye conditions. Int Ophthalmol Clin 1994;34(1):57-69.
  • 30
    Xu KP & Tsubota K. Correlation of the tear clearance rate and fluorophotometric assessment of tear turnover. Br J Ophthalmol 1995;79: 1042-5.
  • 31
    Xu KP, Yagi Y, Toda I & Tsubota K. Tear function index. Arch Ophthalmol 1995; 1134:84-8.
  • 32
    Tsubota K & Nakamori K. Effects of ocular surface area and blink rate on tear dynarnics. Arch Ophthalmol 1995;113:155-8.
  • 33
    Tsubota K & Yamada M. Tear evaporation from the ocular surface. Invest Ophthalmol Vis Sci 1992;33:2942-50.
  • 34
    Gilbard JP, Farris FL & Santamaria J. Osmolarity of tear microvolumes in keratoconjunctivitis sicca. Arch Ophthalmol 1978;96:677-81.
  • 35
    Tabbara KF & Okumoto M. Ocular fernicy test: a qualitative test for mucus deficiency. Ophthalmology 1982;89:712-4.
  • 36
    Morgan PB, Tullo AB & Efron N. Infrared thermography of the tear film in dry eye. Eye 1995;19:615-8.
  • 37
    Fujishima H, Toda I, Yamada M, Sato N & Tsubota K. Corneal temperature in patients with dry eye evaluated by infrared radiation thermometry. Br J Ophthalmol 1996;80:29-32.
  • 38
    Yagi Y, Fujushima H, Shimazaki J & Tsubota K. Cooled eye drops reduce corneal sensation and produce comfortableness. Invest Ophthalmol Vis Sci (Suppl) 1994;35:1671.
  • 39
    Lemp MA. Management of the dry eye patient. Int Ophthalmol Clin 1994;34(1): 101-13.
  • 40
    Lemp MA. Recent developments in dry eye management. In: Cavanagh HD, ed. Transactions of the World Congress on the Cornea III. New York: Raven Press Ltd, 1988;9-13.
  • 41
    Tsubota K. New approaches in dry eye therapy. Int Ophthalmol Clin 1994;34(1):115-28.
  • 42
    Sibley M. Artificial tear issues. Adv Exp Med Biol 1994;350:437-40.
  • 43
    Toda I, Shinozaki N & Tsubota K. Hydroxypropyl methylcellulose for the treatment of severe dry eye associated with Sjögren's syndrome. Cornea 1996;15(2): 120-8.
  • 44
    Murube J & Murube E. Treatment of dry eye by blocking the lacrimal canaliculi. Surv Ophthalmol 1996;40(6):463-80.
  • 45
    Diamond JP, Morgan JE, Virjee J & Easty DL. Canalicular occlusion with cyanoacrylate adhesive: a new treatment for the dry eye. Eye 1995;9:126-9.
  • 46
    Tsubota K, Yamada M & Urayama K. Spectacle side paneis and moist inserts for the treatment of dry eye patients. Cornea 1994;13(3):197-201.
  • 47
    Korb DR, Greiner JV, Glonek J, Esbah R, Finnemore VM & Whalen AC. Effect of periocular hurnidity in tear film lipid layer. Cornea 1996; 15(2): 129-34.
  • 48
    Faarris RL. Contact lenses and the dry eye. Int Ophthalmol Clin 1994;34(1):129-36.
  • 49
    Tseng SCG, Maumenee DE, Stark WJ. Topical retinoids treatment for various dry eye disorders. Ophthalmology 1985;92:917-27.

Datas de Publicação

  • Publicação nesta coleção
    Fev 1999
Creative Common - by 4.0
Este é um artigo publicado em acesso aberto (Open Access) sob a licença Creative Commons Attribution, que permite uso, distribuição e reprodução em qualquer meio, sem restrições desde que o trabalho original seja corretamente citado.
Conselho Brasileiro de Oftalmologia Rua Casa do Ator, 1117 - cj.21, 04546-004 São Paulo SP Brazil, Tel: 55 11 - 3266-4000, Fax: 55 11- 3171-0953 - São Paulo - SP - Brazil
E-mail: abo@cbo.com.br
Acompanhe os números deste periódico no seu leitor de RSS